
Late-stage biotech firm ADMA Biologics has announced it has appointed Lawrence Guiheen to its board of directors. Guiheen said: “Having …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

